Evidence map›Paper›PMID 40969797›Full record

ArticleFrontiers in medicine2025

Emphysematous pyelonephritis: eight case reports and literature review.

Du Jiang, Yang Taoyu, Wu Tao, Peng Xianyue, Gou Chenren, Liang Guobiao

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Du Jiang *Department of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Yang Taoyu *Department of Invasive Technology, Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, Guangdong, China.
Wu TaoDepartment of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Peng XianyueDepartment of Urology, Xinyang 154 Hospital, Xinyang, Henan, China.
Gou ChenrenDepartment of Urology, People's Hospital of Wuchuan, Zunyi, Guizhou, China.
Liang GuobiaoDepartment of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to discuss and summarize the diagnosis and treatment of emphysematous pyelonephritis (EPN). Methods: Retrospective medical records review of all patients diagnosed with EPN from January 2017 to June 2023 in our hospital were analyzed. A total of eight patients (three males and five females) were enrolled. The mean age was 49.38 ± 3.48 years. Among them, one case was complicated by sepsis, two by emphysematous cystitis, two by chronic renal failure, four by diabetes, and five by urolithiasis. Upon admission, all patients received aggressive antimicrobial therapy. Surgical interventions consisted of drainage procedures tailored to each patient's specific condition along with management for upper urinary tract calculi present. Clinical data were analyzed in depth and compared with the previously published studies. Results: All patients complied with the protocol of catheter removal as scheduled and were discharged after complete recovery. No recurrence of infection was recorded during the follow-up. Conclusions: Most EPN patients suffer from severe and complex medical conditions. Selecting an appropriate surgical drainage strategy can significantly reduce the rates of infection recurrence, nephrectomy and mortality, thereby improving the patient's prognosis.

Indexed as

emphysematous pyelonephritisindividualized surgical treatmentprognosissurgical drainagetreatment of comorbidities

Identifiers

PMID40969797
PMCPMC12440937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.